In 2005, DLJMB led the leveraged buyout of Warner Chilcott, a leading specialty pharmaceutical company focused on developing, manufacturing and marketing branded prescription pharmaceutical products. The company focuses on women’s healthcare and dermatology and has established strong brand recognition and penetration with leading products such as Loestrin-24, Taclonex and Dovonex.
Headquarters: Rockaway, NJ